Literature DB >> 8162169

Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts.

M Kassem1, L Mosekilde, E F Eriksen.   

Abstract

The cellular effects of sodium fluoride (NaF) on human bone cells in vitro have been variable and dependent on the culture system used. Variability could be attributed to differences in responsiveness to NaF among different populations of cells at various stages of differentiation in the osteoblastic lineage. In this study we compared the effects of NaF in serum-free medium on cultures of more differentiated human osteoblast-like (hOB) cells derived from trabecular bone explants and on osteoblast committed precursors derived from human bone marrow, i.e. human marrow stromal osteoblast-like (hMS(OB)) cells. Sodium fluoride (10(-5) mol/l) increased proliferation of hMS(OB) cells (p < 0.05, N = 10) but was not mitogenic to hOB cells (p > 0.05, N = 10). Alkaline phosphatase (AP) production increased in both hMS(OB) (p < 0.05, N = 9) and hOB cells (p < 0.05, N = 9). No significant effects on procollagen type I propeptide production were obtained in either culture. In the presence of 1,25-dihydroxycholecalciferol (10(-9) mol/l), NaF enhanced alkaline phosphatase (p < 0.05, N = 8), procollagen type I propeptide (p < 0.05, N = 7) and osteocalcin (p < 0.05, N = 7) production by hMS(OB) cells but not by hOB cells. Our results suggest that osteoblast precursors are more sensitive to NaF action than mature osteoblasts and that the in vivo effects of NaF on bone formation may be mediated by stimulating proliferation and differentiation of committed osteoblast precursors in bone marrow.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162169     DOI: 10.1530/eje.0.1300381

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Effects of serum and serum heat-inactivation on human bone derived osteoblast progenitor cells.

Authors:  A Bruinink; U Tobler; M Hälg; J Grünert
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

2.  Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cells in vitro.

Authors:  J Takada; T Chevalley; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1996-05       Impact factor: 4.333

3.  Does sodium fluoride in bone cement affect implant fixation? Part I: bone tissue response, implant fixation and histology in nine rabbits.

Authors:  Mikael Sundfeldt; Michael Widmark; Ann Wennerberg; Johan Kärrholm; Carina B Johansson; Lars V Carlsson
Journal:  J Mater Sci Mater Med       Date:  2002-11       Impact factor: 3.896

4.  Surface properties and ion release from fluoride-containing bioactive glasses promote osteoblast differentiation and mineralization in vitro.

Authors:  E Gentleman; M M Stevens; R G Hill; D S Brauer
Journal:  Acta Biomater       Date:  2012-11-02       Impact factor: 8.947

Review 5.  Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis.

Authors:  P Vestergaard; N R Jorgensen; P Schwarz; L Mosekilde
Journal:  Osteoporos Int       Date:  2007-08-15       Impact factor: 4.507

6.  Comparative study of hydroxyapatite, fluor-hydroxyapatite and Si-substituted hydroxyapatite nanoparticles on osteogenic, osteoclastic and antibacterial ability.

Authors:  Jing Sun; Tao Wu; Qihang Fan; Qing Hu; Bin Shi
Journal:  RSC Adv       Date:  2019-05-22       Impact factor: 4.036

7.  Zirconium ions up-regulate the BMP/SMAD signaling pathway and promote the proliferation and differentiation of human osteoblasts.

Authors:  Yongjuan Chen; Seyed-Iman Roohani-Esfahani; ZuFu Lu; Hala Zreiqat; Colin R Dunstan
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

Review 8.  Modifications of Dental Implant Surfaces at the Micro- and Nano-Level for Enhanced Osseointegration.

Authors:  In-Sung Luke Yeo
Journal:  Materials (Basel)       Date:  2019-12-23       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.